The present invention provides a composition comprising HMB and Vitamin D. Methods of administering HMB and Vitamin D to an animal are also described. Vitamin D and HMB are administered to increase muscle mass, strength, and functionality. The combination of Vitamin D and HMB together has a synergistic effect, which results in a surprising and unexpected level of improvement in muscle mass, strength and functionality.

This invention relates to the use of the combination of 25-hydroxyvitamin D3 (25-OH D3) and antioxidants/anti-inflammatories (ascorbic acid, vitamin E and at least one carotenoid) to make a pharmaceutical, nutraceutical or food supplement which can ameliorate various problems observed in humans connected with polycystic ovarian 5 syndrome and cardiovascular diseases. Pharmaceuticals, nutraceuticals and food supplements containing the 25-OH D3 and antioxidants/anti-inflammatories and premixes are also provided.

This invention relates to the use of the combination of 25-hydroxyvitamin D3 (25-OH D3) and antioxidants/anti-inflammatories (ascorbic acid, vitamin E and at least one carotenoid) to make a pharmaceutical, nutraceutical or food supplement which can ameliorate various problems observed in humans connected with polycystic ovarian 5 syndrome and cardiovascular diseases. Pharmaceuticals, nutraceuticals and food supplements containing the 25-OH D3 and antioxidants/anti-inflammatories and premixes are also provided.

A formulation for a dietary supplement includes standardized extracts of astragalus root, phlorizin, root bark of white mulberry, olive leaf, and bitter melon. The formulation may further include chromium, 2-deoxy-D-glucose, biotin, vitamin D and vitamin C. A method of controlling postprandial blood glucose includes administering the formulation for the dietary supplement to a patient.

The invention relates to means for preventing and treating conditions associated with acute respiratory diseases and flu, as well as for immunity improvement. The proposed biologically active additive comprises adsorbed drone brood homogenate, the daily dose thereof lying between 75 mg and 500 mg, and vitamin or vitamins of group D and/or their active metabolites, a daily dose thereof being between 25 IE and 50,000 IE.

The invention relates to means for preventing and treating conditions associated with acute respiratory diseases and flu, as well as for immunity improvement. The proposed biologically active additive comprises adsorbed drone brood homogenate, the daily dose thereof lying between 75 mg and 500 mg, and vitamin or vitamins of group D and/or their active metabolites, a daily dose thereof being between 25 IE and 50,000 IE.

A feeding regimen for an infant which includes (a) providing a first composition comprising a fat or lipid; a protein source, wherein the protein source has from about 72% to about 90% whey and from about 10% to about 28% casein; a prebiotic composition; and at least about 72 IU/100 kcal of vitamin D, (b) instructing that the first composition is to be fed to an infant from birth through 4 months of age; (c) providing a second composition, the second composition comprising: a fat or lipid; a protein source, wherein the protein source has from about 50% to about 70% whey and from about 30% to about 50% casein; a prebiotic composition; and no greater than 70 IU/100 kcal of vitamin D; and (d) instructing that the second composition is to be fed to an infant starting at 4 months of age.

A feeding regimen for an infant which includes (a) providing a first composition comprising a fat or lipid; a protein source, wherein the protein source has from about 72% to about 90% whey and from about 10% to about 28% casein; a prebiotic composition; and at least about 72 IU/100 kcal of vitamin D, (b) instructing that the first composition is to be fed to an infant from birth through 4 months of age; (c) providing a second composition, the second composition comprising: a fat or lipid; a protein source, wherein the protein source has from about 50% to about 70% whey and from about 30% to about 50% casein; a prebiotic composition; and no greater than 70 IU/100 kcal of vitamin D; and (d) instructing that the second composition is to be fed to an infant starting at 4 months of age.

Provided is a composition for improving the nutritional status, reducing the frequency of fever, and/or increasing the immunocompetence of the elderly. The composition is one for improving the nutritional status, reducing the frequency of fever, and/or increasing the immunocompetence of the elderly and comprises the following components (a) to (e): (a) an antioxidant agent; (b) at least one component selected from the group consisting of vitamin B.sub.1, vitamin B.sub.2, vitamin B.sub.6, niacin, and pantothenic acid; (c) at least one component selected from the group consisting of folic acid and vitamin B.sub.12; (d) zinc; and (e) selenium.

Provided is a composition for improving the nutritional status, reducing the frequency of fever, and/or increasing the immunocompetence of the elderly. The composition is one for improving the nutritional status, reducing the frequency of fever, and/or increasing the immunocompetence of the elderly and comprises the following components (a) to (e): (a) an antioxidant agent; (b) at least one component selected from the group consisting of vitamin B.sub.1, vitamin B.sub.2, vitamin B.sub.6, niacin, and pantothenic acid; (c) at least one component selected from the group consisting of folic acid and vitamin B.sub.12; (d) zinc; and (e) selenium.